Clinical Trial Update: Immune Response to High-Dose vs. Standard Dose Influenza Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing immune response to high-dose versus standard-dose influenza vaccine in elderly individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elderly Immune System
• Influenza in the Elderly

Snippet

Sponsor: Health Sciences North Research Institute | Conditions: Elderly Immune System | Phase 4 | Status: UNKNOWN